NYSE:ANRO | Cash Flow Statement | Alto Neuroscience, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$27.64M
2026-03-31-$26.24M-$27.09M$556,000.00-$556,000.00$114.94M
2025-12-31-$16.18M-$11.52M$0.00$0.00$50.19M
2025-09-30-$14.18M
2025-06-30-$17.71M$100,000.00
2025-03-31-$15.17M$171,000.00-$16.56M$24,000.00-$24,000.00$9.13M
2024-12-31-$15.2M$170,000.00-$13.02M$506,000.00-$506,000.00$49,000.00
2024-09-30-$16.78M$200,000.00
2024-06-30-$16.03M$100,000.00
2024-03-31-$13.42M$97,000.00-$10.98M$224,000.00-$224,000.00$134.56M
2023-12-31-$11.22M$112,000.00-$11.52M$352,000.00-$352,000.00$43.13M
2023-09-30-$9.14M$100,000.00
2023-06-30-$8.66M$100,000.00
2023-03-31-$7.28M$86,000.00-$7.52M$21,000.00-$21,000.00$25M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$63.24M-$51.77M$24,000.00-$24,000.00$60.08M
2024-12-31-$61.43M$502,000.00-$47.42M$2.08M-$2.08M$135.69M
2023-12-31-$36.31M$373,000.00-$33.45M$470,000.00-$470,000.00$68.13M